On #WorldMenstrualHygieneDay, Barinthus associate project manager Lizzy Welsh speaks about the importance of raising awareness and ending the stigma surrounding menstruation and hormonal changes in the workplace. #MHDay2024
Barinthus Biotherapeutics’ Post
More Relevant Posts
-
Our Chief Business Officer Graham Griffiths is on the move, meeting with people from all over the globe! Recently he traveled to China and spoke with potential investors and partners about Barinthus Bio’s innovative platform and portfolio of potential treatments for serious diseases. Learn how Barinthus Bio is advancing the next generation of antigen-specific immunotherapies for treating chronic infectious diseases, #autoimmunity and #cancer: https://lnkd.in/ewaij6jM #innovation #partnering #hepatitis #biopharma
Last week I joined a delegation of companies that visited Shanghai, Nanjing and Wuxi to explore opportunities for #biotech partnership and investment. Huge thanks 🤜 to the wonderful and impressive team at #HSBC and our many hosts in China for a fascinating, fun and productive trip with an amazing group of people representing great companies - including the opportunity to introduce spread the word about Barinthus Bio and its portfolio of medicines designed to treat #autoimmunity #cancer and #infectiousdiseases by inducing antigen-specific T cells. Simon Bumfrey Cora McLaren Joe Li Sherard Cowper-Coles China-Britain Business Council
-
-
At Barinthus Biotherapeutics we are celebrating #PRIDE month and supporting our #LGBTQIA+ community because diversity isn’t just beneficial—it’s essential for driving innovation and success. We strive to create an environment where every individual feels valued, respected, and empowered to bring their authentic self to work. #biotech #unity
-
-
#RECAP: Another whirlwind year at EASL | The Home of Hepatology annual conference in Milan, Italy. Our team, along with our partners at Arbutus Biopharma Corporation, were honored to share our research and #clinicaltrial findings as we work towards positively changing outcomes for people with #HepatitisB. Learn more about our poster and oral presentations at #EASL2024 here: https://lnkd.in/eXXAYkAz
-
-
At Barinthus, we’re focused on improving patient outcomes. As our Chief Business Officer Graham Griffiths puts it, meetings like #EASL2024 bring together a community of people who are passionate about working towards curing serious diseases. Read more about our work at this year’s EASL | The Home of Hepatology Congress: https://lnkd.in/eXXAYkAz #HepatitisB #innovation #biopharma #EASLcongress
-
“We believe these data are further evidence that VTP-300 could be a critical component of a functional cure regimen.” For #HCPs: Today our CEO Bill Enright explains how the new interim data, presented at the EASL | The Home of Hepatology 2024 Congress, shows our progress towards reshaping the #HepatitisB treatment landscape. Read more: https://lnkd.in/eXXAYkAz #EASL2024 #innovation #hepatitis #HBV #TheLiverMeeting2024 #EASLMeeting
-
-
Our VP of Corporate Development, Nick Fullenkamp, and Chief Scientific Officer, Nadege Pelletier, are at Biotechnology Innovation Organization #BIO2024. Schedule a meeting with us in San Diego to learn more about #partnering opportunities: https://lnkd.in/eEDtKaAK #immunotherapy #innovation #celiac #HBV #investors
-
-
Our Chief Scientific Officer, Dr. Nadege Pelletier, has been featured in Health and Pharma during #HepatitisAwarenessMonth. Nadege details our #innovation and progress as we work towards advancing a potential functional cure for #hepatitisB: https://lnkd.in/ds5xsiEk #HepB #immunotherapy #biotechnews
-
#ICYMI: Our CBO Graham Griffiths reflects on recent news of #MERS cases in Saudi Arabia. Read more 👇
The #pandemic underscored the impact that viruses can have on our lives, and the latest news of #MERS cases in Saudi Arabia is a reminder of the importance of a global public health strategy that addresses these risks. Barinthus Biotherapeutics, in collaboration with CEPI and the University of Oxford, along with other key industry players, continues to prioritize the development of treatments and vaccines for infectious viral diseases. Our thoughts are with the MERS-CoV victims and their families, and we remain steadfast in our work towards fast-tracking the development of the MERS vaccine candidate: https://lnkd.in/e_GvAWCv #mednews
-
Research Scientist, Allogeneic T-cell therapy
1moWell put Elizabeth Welsh 👏🏻